AB
Avicenna Biosciences, Inc.
SEC filingBiotechnology · Durham, NC
Amount raised$71Ksold at filing
Total offering$71K
Investors in the raise1count reported to the SEC
FiledOct 30, 2025first sale Feb 17, 2022
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Pieter BurgerExecutive Officer, Director
John HamerDirector
Dennis LangerDirector
Thomas KaiserExecutive Officer, Director
Christopher MeldrumExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.